UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011031 |
|---|---|
| Receipt number | R000012915 |
| Scientific Title | A phase II study of neoadjuvant docetaxel/cyclophosphamide (DC) followed by epirubicin/cyclophosphamide (EC) for triple-negative breast cancer |
| Date of disclosure of the study information | 2013/06/24 |
| Last modified on | 2018/03/05 18:26:19 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/06/24 20:49:55 | ||
| 2 | Update | 2013/10/02 10:28:35 | Email |
|
| 3 | Update | 2013/10/02 10:29:40 | Recruitment status |
|
| 4 | Update | 2018/03/05 18:25:28 | Name of primary person or sponsor Organization Organization Organization |
|
| 5 | Update | 2018/03/05 18:26:19 | Recruitment status |
